Schools are where kids spend most of their time, so strange things keep happening. One netizen asked people to share the ...

Preclinical evidence supports azenosertib ADC combinations as potential promising therapeutic strategies for Triple-Negative Breast Cancer  Demonstration of Cyclin E1 protein overexpression as an ...

Cibus, Inc. (Nasdaq: CBUS) (the 'Company'), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ...

It ended up causing over $40,000 in damages and did cancel school for one day, and the police came to the school to do interviews all that week. Apparently, most of them got away with it because of ...

TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...

Here comes Big Brother. Senate Bill 2461 would ban some common pre-implantation genetic tests used in IVF care to screen for hundreds of hereditary, genetic disorders, such as Tay-Sachs disease, ...

CBSE Class 10th Board Exam Dates: LOC submission begins March 18; CBSE outlines eligibility, phases, and rules for May 2026 second board exams ...

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness -CUE-401 is the Company's lead asset for the treatment of autoimmune and inflammatory diseasesAppointed indust ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and rema ...